The extracellular matrix component perlecan/HSPG2 regulates radioresistance in prostate cancer cells.
Samaržija I, Lukiyanchuk V, Lončarić M, Rac-Justament A, Stojanović N, Gorodetska I, Kahya U, Humphries JD, Fatima M, Humphries MJ, Fröbe A, Dubrovska A, Ambriović-Ristov A.
Samaržija I, et al. Among authors: stojanovic n.
Front Cell Dev Biol. 2024 Aug 1;12:1452463. doi: 10.3389/fcell.2024.1452463. eCollection 2024.
Front Cell Dev Biol. 2024.
PMID: 39149513
Free PMC article.